Safety and Pharmacokinetic Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke

Clinical trial NCT00870844 · COMPLETED

Trial details

NCT number: NCT00870844
Sponsor: H. Lundbeck A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2009-05-01
Primary completion: 2010-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.